Active ingredients: Ciprofibrate

Product name and form

Ciprofibrate 100mg Tablets.

Pharmaceutical Form


White to off white round tablets with a breakline on one side and embossed ‘S170’ on the other.

Qualitative and quantitative composition

Each tablet contains 100mg ciprofibrate as the active ingredient.

For excipients, see 6.1.

Active Ingredient

Ciprofibrate is a new derivative of phenoxyisobutyric acid which has a marked hypolipidaemic action. It reduces both LDL and VLDL and hence the levels of triglyceride and cholesterol associated with these lipoprotein fractions. It also increases levels of HDL cholesterol.

List of Excipients

Maize starch
Lactose monohydrate
Microcrystalline cellulose
Powdered vegetable stearine
Sodium laurilsulfate

Pack sizes and marketing

Clear PVC/Aluminium blister strips in packs of 28 tablets.

Amber glass bottles of 100 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Zentiva Pharma UK Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom

Trading as: Zentiva, One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Marketing authorization dates and numbers

PL 17780/0456

18 June 2009